Dr Zil a Rubab - Research

Immunogenomic biomarkers and immunoregulatory pathways in head and neck squamous Cell Carcinoma to identify immunotherapies – Era of New Hope -2023 (Pakistan Science Foundation)
Gene and Chimeric antigen receptor (CAR)-T cell therapy- Small Business innovation Research Program, Nanocan Therapeutic Corporation, USA- 2021
Liquid immunogenic Fiducial Eluter (LIFE) Gel for oral cancer- Small Business innovation Research Program, Nanocan Therapeutic Corporation, USA- 2022

Expression of Tumor Necrosis Factor Receptor Superfamily Member 4 and its ligand (OX40 And OX40L) in oral squamous cell carcinoma- 2022
Association of soluble C-type lectin-like receptor 2 (CLEC-2) with coronary artery disease-0 2023
Salivary Fetuin- A levels in myocardial infarction with and without periodontitis- 2022
Gene polymorphism of FTO, KCNQ1 AND JAZF1 in adults with parental history of Diabetes Mellitus
SLC30A8 polymorphism (rs13266634) and autoantibodies against ZnT8 in Type 1 Diabetes Mellitus -2021
Association of rs9939609 FTO gene variant with obesity among Karachi adults using oral rinse - 2020

Expression of Tumor Necrosis Factor Receptor Superfamily Member 4 and its ligand (OX40 And OX40L) in oral squamous cell carcinoma - 2022
Association of soluble C-type lectin-like receptor 2 (CLEC-2) with coronary artery disease- 2023
Salivary Fetuin- A levels in myocardial infarction with and without periodontitis -2022
Gene polymorphism of FTO, KCNQ1 AND JAZF1 in adults with parental history of Diabetes Mellitus- 2021